Literature DB >> 26772149

Risk of Recurrent Pancreatitis and Progression to Chronic Pancreatitis After a First Episode of Acute Pancreatitis.

Usama Ahmed Ali1, Yama Issa2, Julia C Hagenaars3, Olaf J Bakker3, Harry van Goor4, Vincent B Nieuwenhuijs5, Thomas L Bollen6, Bert van Ramshorst7, Ben J Witteman8, Menno A Brink9, Alexander F Schaapherder10, Cornelis H Dejong11, B W Marcel Spanier12, Joos Heisterkamp13, Erwin van der Harst14, Casper H van Eijck15, Marc G Besselink2, Hein G Gooszen16, Hjalmar C van Santvoort2, Marja A Boermeester17.   

Abstract

BACKGROUND & AIMS: Patients with a first episode of acute pancreatitis can develop recurrent or chronic pancreatitis (CP). However, little is known about the incidence or risk factors for these events.
METHODS: We performed a cross-sectional study of 669 patients with a first episode of acute pancreatitis admitted to 15 Dutch hospitals from December 2003 through March 2007. We collected information on disease course, outpatient visits, and hospital readmissions, as well as results from imaging, laboratory, and histology studies. Standardized follow-up questionnaires were sent to all available patients to collect information on hospitalizations and interventions for pancreatic disease, abdominal pain, steatorrhea, diabetes mellitus, medications, and alcohol and tobacco use. Patients were followed up for a median time period of 57 months. Primary end points were recurrent pancreatitis and CP. Risk factors were evaluated using regression analysis. The cumulative risk was assessed using Kaplan-Meier analysis.
RESULTS: Recurrent pancreatitis developed in 117 patients (17%), and CP occurred in 51 patients (7.6%). Recurrent pancreatitis developed in 12% of patients with biliary disease, 24% of patients with alcoholic etiology, and 25% of patients with disease of idiopathic or other etiologies; CP occurred in 3%, 16%, and 10% of these patients, respectively. Etiology, smoking, and necrotizing pancreatitis were independent risk factors for recurrent pancreatitis and CP. Acute Physiology and Chronic Health Evaluation II scores at admission also were associated independently with recurrent pancreatitis. The cumulative risk for recurrent pancreatitis over 5 years was highest among smokers at 40% (compared with 13% for nonsmokers). For alcohol abusers and current smokers, the cumulative risks for CP were similar-approximately 18%. In contrast, the cumulative risk of CP increased to 30% in patients who smoked and abused alcohol.
CONCLUSIONS: Based on a retrospective analysis of patients admitted to Dutch hospitals, a first episode of acute pancreatitis leads to recurrent pancreatitis in 17% of patients, and almost 8% of patients progress to CP within 5 years. Progression was associated independently with alcoholic etiology, smoking, and a history of pancreatic necrosis. Smoking is the predominant risk factor for recurrent disease, whereas the combination of alcohol abuse and smoking produces the highest cumulative risk for chronic pancreatitis.
Copyright © 2016 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chronic Pancreatitis; Longitudinal Study; Pancreatitis Progression; Risk Factors

Mesh:

Year:  2016        PMID: 26772149     DOI: 10.1016/j.cgh.2015.12.040

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  71 in total

Review 1.  Chronic Pancreatitis and the Development of Pancreatic Cancer.

Authors:  Hemanth K Kandikattu; Sathisha U Venkateshaiah; Anil Mishra
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2020       Impact factor: 2.895

2.  An Evaluation of Factors Associated With Pathogenic PRSS1, SPINK1, CTFR, and/or CTRC Genetic Variants in Patients With Idiopathic Pancreatitis.

Authors:  Niloofar Y Jalaly; Robert A Moran; Farshid Fargahi; Mouen A Khashab; Ayesha Kamal; Anne Marie Lennon; Christi Walsh; Martin A Makary; David C Whitcomb; Dhiraj Yadav; Liudmila Cebotaru; Vikesh K Singh
Journal:  Am J Gastroenterol       Date:  2017-04-25       Impact factor: 10.864

3.  Diagnosis of Chronic Pancreatitis Incorporating Endosonographic Features, Demographics, and Behavioral Risk.

Authors:  Linda S Lee; Ying P Tabak; Vivek Kadiyala; Xiaowu Sun; Shadeah Suleiman; Richard S Johannes; Peter A Banks; Darwin L Conwell
Journal:  Pancreas       Date:  2017-03       Impact factor: 3.327

4.  Chronic Pancreatitis in the 21st Century - Research Challenges and Opportunities: Summary of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

Authors:  Aliye Uc; Dana K Andersen; Melena D Bellin; Jason I Bruce; Asbjørn M Drewes; John F Engelhardt; Christopher E Forsmark; Markus M Lerch; Mark E Lowe; Brent A Neuschwander-Tetri; Stephen J OʼKeefe; Tonya M Palermo; Pankaj Pasricha; Ashok K Saluja; Vikesh K Singh; Eva M Szigethy; David C Whitcomb; Dhiraj Yadav; Darwin L Conwell
Journal:  Pancreas       Date:  2016-11       Impact factor: 3.327

Review 5.  Total pancreatectomy for recurrent acute and chronic pancreatitis: a critical review of patient selection criteria.

Authors:  Mahya Faghih; Francisco Garcia Gonzalez; Martin A Makary; Vikesh K Singh
Journal:  Curr Opin Gastroenterol       Date:  2017-09       Impact factor: 3.287

6.  Progression of recurrent acute to chronic pancreatitis: More questions than answers!

Authors:  Rupjyoti Talukdar
Journal:  Indian J Gastroenterol       Date:  2018-03

7.  Radiomics model of contrast-enhanced computed tomography for predicting the recurrence of acute pancreatitis.

Authors:  Yong Chen; Tian-Wu Chen; Chang-Qiang Wu; Qiao Lin; Ran Hu; Chao-Lian Xie; Hou-Dong Zuo; Jia-Long Wu; Qi-Wen Mu; Quan-Shui Fu; Guo-Qing Yang; Xiao Ming Zhang
Journal:  Eur Radiol       Date:  2018-11-09       Impact factor: 5.315

Review 8.  Lipocalin-2 expression and function in pancreatic diseases.

Authors:  Kristyn Gumpper; Andrew William Dangel; Valentina Pita-Grisanti; Somashekar G Krishna; Luis F Lara; Thomas Mace; Georgios I Papachristou; Darwin L Conwell; Phil A Hart; Zobeida Cruz-Monserrate
Journal:  Pancreatology       Date:  2020-01-07       Impact factor: 3.996

9.  STING signalling protects against chronic pancreatitis by modulating Th17 response.

Authors:  Qinglan Zhao; Murli Manohar; Yi Wei; Stephen J Pandol; Aida Habtezion
Journal:  Gut       Date:  2019-01-31       Impact factor: 23.059

Review 10.  New Advances in the Treatment of Acute Pancreatitis.

Authors:  Mahya Faghih; Christopher Fan; Vikesh K Singh
Journal:  Curr Treat Options Gastroenterol       Date:  2019-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.